Across TCGA cell cohorts, CCDC160 mutation is significantly associated with the RNA expression of many other genes, with 13 significant associations in total. BLOOD_Leukemia shows the largest number of these associations.

The most reproducible CCDC160-associated genes across cancer lineages are MYF5, GPR6, and OR52E4. Each is linked with CCDC160 in more than 1 cancer types. Because this analysis shows association rather than direction, both CCDC160-to-partner and partner-to-CCDC160 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (CCDC160→partner) and Y-score (partner→CCDC160) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
BLOOD_Leukemia	MYF5 →	+0.006	+5.201	.003	.006	3	1
BLOOD_Leukemia	GPR6 →	+0.022	+4.922	<.001	.009	3	1
BLOOD_Leukemia	OR52E4 →	+0.015	+5.201	<.001	.006	3	1
BLOOD_Leukemia	ACSM2A →	+0.013	+5.969	<.001	.001	3	1
BLOOD_Leukemia	OR4F6 →	+0.015	+4.922	.003	.009	3	1
BLOOD_Leukemia	ZCCHC13 →	+0.030	+6.569	<.001	<.001	3	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 13 associations by consensus.

Exploration

CCDC160 survival (RNA) · tumor vs normal (RNA) · all CCDC160 data types